To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Kashin-Beck disease: Chondroitin sulfate plus Glucosamine reduces pain and stiffness

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
August 2013

Kashin-Beck disease: Chondroitin sulfate plus Glucosamine reduces pain and stiffness

Vol: 2| Issue: 7| Number:254| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study

Osteoarthritis Cartilage. 2012 Jul;20(7):622-9. Epub 2012 Mar 30.

Contributing Authors:
J Yue M Yang S Yi B Dong W Li Z Yang J Lu R Zhang J Yong

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

251 patients with Kashin-Beck disease (KBD) were randomized to receive oral administration of either chondroitin sulfate, glucosamine hydrochloride, a combination of chondroitin sulfate and glucosamine hydrochloride, or a placebo. The results following 6 months of treatment indicate that the combined treatment of chondroitin sulfate and glucosamine hydrochlroide is more effective in providing KBD ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.